Alcove RTP Market Roundup 11/10/2023
Featured listings

Alcove RTP Market Roundup 11/10/2023

Alcove Team | 11/10/23
The RTP real estate market is showing significant activity this fall. This update provides insights into new listings and recent sales in the area, coupled with exciting regional news. Here's what's happening in the Raleigh-Durham market:
MOVE Program Connects Veterans and Military Members to Careers in the Life Sciences Industry
Raleigh-Durham News

MOVE Program Connects Veterans and Military Members to Careers in the Life Sciences Industry

Alcove Team | 11/9/23
A statewide program called MOVE is helping veterans and military members transition into careers in the life sciences industry by providing training and job placement opportunities.
Morrisville's Smart City Journey: Enhancing Quality of Life and Economic Development
Raleigh-Durham News

Morrisville's Smart City Journey: Enhancing Quality of Life and Economic Development

Alcove Team | 11/9/23
The Town of Morrisville in North Carolina is leading the way in smart city innovation, using data from sensors to improve services and promote economic growth.
Wake Forest Commercial Space Sells for $300,000
Raleigh-Durham News

Wake Forest Commercial Space Sells for $300,000

Alcove Team | 11/9/23
A commercial space in Wake Forest has been sold for $300,000.
Potential Breakthrough: Duke Researchers Develop Method to Annihilate Lyme Disease Bacteria
Raleigh-Durham News

Potential Breakthrough: Duke Researchers Develop Method to Annihilate Lyme Disease Bacteria

Alcove Team | 11/9/23
A Duke Health team has discovered a way to use a molecular warhead to effectively eliminate the bacterium that causes Lyme disease, offering a promising alternative to traditional antibiotics.
FUJIFILM Diosynth Biotechnologies Unveils New Facility in Holly Springs
Raleigh-Durham News

FUJIFILM Diosynth Biotechnologies Unveils New Facility in Holly Springs

Alcove Team | 11/8/23
FUJIFILM Diosynth Biotechnologies (FDB) celebrated the unveiling of its new site in Holly Springs, which will be the largest end-to-end cell culture contract development and manufacturing organization (CDMO) biopharmaceutical manufacturing facility in North America. Janssen, a Johnson & Johnson company, will be the first tenant at the facility when it opens in 2025.
. . .
. . .